Perbedaan Indofarma Tbk. dan Kokoh Exa Nusantara Tbk: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Kokoh Exa Nusantara Tbk diperdagangkan di Rp134 (kapitalisasi pasar 576,31 M, volume 24 jam 60,42 jt). Perbedaan utamanya: Kokoh Exa Nusantara Tbk lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | KOCI | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 576,31 M |
Volume | — | 60,42 jt |
Lot | — | 604,22 rb |
Perputaran | — | 7,95 M |
Harga Rata-rata | — | 131,63 |
Nilai Transaksi | — | 7,95 M |
Harga Ekuilibrium Indikatif | — | 134 |
Volume Ekuilibrium Indikatif | — | 5,59 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.
Selengkapnya di halaman KOCI →